By the same authors

From the same journal

A systematic review of the clinical effectiveness and cost effectiveness of topotecan, pegylated liposomal doxorubicin hydrocholoride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer (up-date).

Research output: Contribution to journalArticle

Author(s)

Department/unit(s)

Publication details

JournalHealth Technol Assess.
DatePublished - 2006
Volume10(9):
Number of pages173
Pages (from-to)1-173
Original languageEnglish

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations